Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: Oral Statins and Protection From Hearing Loss [Phase 4]

View source ↗

Summary

Northwestern University is conducting a Phase 4 trial to investigate whether oral statins can protect against sudden sensorineural hearing loss. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Statins

Snippet

Sponsor: Northwestern University | Conditions: Sudden Sensorineural Hearing Loss | Phase 4 | Status: RECRUITING